We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Medgenics On Target To Start Phase I/II Clinical Trials With EPODURE Protein Therapy For Anaemia Mid-2008 As Planned
Blood / Hematology Medgenics (AIM:MEDG), the US-incorporated biopharmaceutical company, is pleased to provide an update on progress towards the start of its Phase I/II clinical trials with EPODURE, its lead sustained-action protein therapy for producing and delivering erythropoietin (EPO) to treat anaemia. The Company continues to make excellent progress with its preparations to commence Phase I/II trials of EPODURE and remains confident it will begin these trials by mid-2008 as planned.
Custom Search
